On the public citation graph
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells
0 signed · 153 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2016.13985openalex-snapshot
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
inferredcites →https://doi.org/10.1002/hep.29229openalex-snapshot
Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity
inferredcites →https://doi.org/10.1002/path.4630openalex-snapshot
Local effects of human PCSK9 on the atherosclerotic lesion
inferredcites →https://doi.org/10.1007/s00395-020-00832-wopenalex-snapshot
PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2014.04.001openalex-snapshot
Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2016.03.010openalex-snapshot
PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2017.04.023openalex-snapshot
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2019.08.014openalex-snapshot
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
inferredcites →https://doi.org/10.1016/j.bbrc.2008.07.023openalex-snapshot
Inflammation stimulates the expression of PCSK9
inferredcites →https://doi.org/10.1016/j.jacc.2013.07.056openalex-snapshot
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
inferredcites →https://doi.org/10.1016/j.jacc.2021.04.102openalex-snapshot
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
inferredcites →https://doi.org/10.1016/j.jcmg.2019.06.022openalex-snapshot
PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers
inferredcites →https://doi.org/10.1016/j.jid.2019.05.017openalex-snapshot
SIRT3 Regulates Macrophage-Mediated Inflammation in Diabetic Wound Repair
inferredcites →https://doi.org/10.1016/j.molmet.2021.101337openalex-snapshot
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
inferredcites →https://doi.org/10.1016/j.mvr.2022.104371openalex-snapshot
PCSK9 inhibition protects against myocardial ischemia-reperfusion injury via suppressing autophagy
inferredcites →https://doi.org/10.1016/j.redox.2021.101915openalex-snapshot
Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosis
inferredcites →https://doi.org/10.1016/j.redox.2022.102390openalex-snapshot
Adiponectin/AdiopR1 signaling prevents mitochondrial dysfunction and oxidative injury after traumatic brain injury in a SIRT3 dependent manner
inferredcites →https://doi.org/10.1038/s41467-021-23923-1openalex-snapshot
IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation
inferredcites →https://doi.org/10.1038/s41569-018-0107-8openalex-snapshot
PCSK9 inhibitors: clinical evidence and implementation
inferredcites →https://doi.org/10.1038/s41598-018-20425-xopenalex-snapshot
PCSK9 induces a pro-inflammatory response in macrophages
inferredcites →https://doi.org/10.1038/s41598-018-35890-7openalex-snapshot
SIRT3 deficiency-induced mitochondrial dysfunction and inflammasome formation in the brain
inferredcites →https://doi.org/10.1056/nejmoa1615664openalex-snapshot
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
inferredcites →https://doi.org/10.1073/pnas.222538099openalex-snapshot
SIRT3, a human SIR2 homologue, is an NAD- dependent deacetylase localized to mitochondria
inferredcites →https://doi.org/10.1080/13813455.2020.1788605openalex-snapshot
Evolocumab, a PCSK9 inhibitor, protects human endothelial cells against H 2 O 2 -induced oxidative stress
inferredcites →https://doi.org/10.1089/ars.2013.5347openalex-snapshot
Regulation Where Autophagy Intersects the Inflammasome
inferredcites →https://doi.org/10.1089/ars.2014.6054openalex-snapshot
Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
inferredcites →https://doi.org/10.1093/cvr/cvy079openalex-snapshot
PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages
inferredcites →https://doi.org/10.1093/cvr/cvy128openalex-snapshot
PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy
inferredcites →https://doi.org/10.1093/eurheartj/ehz455openalex-snapshot
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
inferredcites →https://doi.org/10.1111/bcp.12905openalex-snapshot
Effect of monoclonal antibodies to PCSK9 on high‐sensitivity C‐reactive protein levels: a meta‐analysis of 16 randomized controlled treatment arms
inferredcites →https://doi.org/10.1111/joim.12758openalex-snapshot
PCSK 9 plays a novel immunological role in oxidized LDL‐induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
inferredcites →https://doi.org/10.1128/mcb.00426-08openalex-snapshot
SIRT3 Is a Stress-Responsive Deacetylase in Cardiomyocytes That Protects Cells from Stress-Mediated Cell Death by Deacetylation of Ku70
inferredcites →https://doi.org/10.1136/openhrt-2017-000765openalex-snapshot
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
inferredcites →https://doi.org/10.1155/2018/7293861openalex-snapshot
SIRT3: A New Regulator of Cardiovascular Diseases
inferredcites →https://doi.org/10.1161/01.res.0000115557.25127.8dopenalex-snapshot
Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor
inferredcites →https://doi.org/10.1161/01.str.0000231685.82795.e5openalex-snapshot
Statin Treatment Is Not Associated With Consistent Alterations in Inflammatory Status of Carotid Atherosclerotic Plaques
inferredcites →https://doi.org/10.1161/circresaha.108.188318openalex-snapshot
Autophagy in Atherosclerosis
inferredcites →https://doi.org/10.1161/circresaha.121.319077openalex-snapshot
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
inferredcites →https://doi.org/10.1161/circulationaha.120.049447openalex-snapshot
Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol
inferredcites →https://doi.org/10.1177/0004563217705053openalex-snapshot
Evolocumab and clinical outcomes in patients with cardiovascular disease
inferredcites →https://doi.org/10.1186/s12950-019-0212-4openalex-snapshot
Role of autophagy in atherosclerosis: foe or friend?
inferredcites →https://doi.org/10.1210/me.2007-0079openalex-snapshot
Sirtuin Functions in Health and Disease
inferredcites →https://doi.org/10.18632/aging.102375openalex-snapshot
Sirtuin 3 attenuates neuroinflammation-induced apoptosis in BV-2 microglia
inferredcites →https://doi.org/10.3390/antiox9040296openalex-snapshot
PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
inferredcites →https://doi.org/10.3390/cells9112510openalex-snapshot
SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis
inferredcites →https://doi.org/10.3390/ijms22137193openalex-snapshot
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
inferredcites →https://doi.org/10.3390/ijms23031448openalex-snapshot
Pleiotropic, Unique and Shared Responses Elicited by IL-6 Family Cytokines in Human Vascular Endothelial Cells
inferredcites →https://doi.org/10.3390/jcdd9050127openalex-snapshot
The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels
inferredcites →https://doi.org/10.3390/ph15070802openalex-snapshot
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
inferredcites →https://doi.org/10.3892/mmr.2017.6803openalex-snapshot
Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
inferredcites →https://doi.org/10.5607/en21021openalex-snapshot
Overexpression of SIRT3 Suppresses Oxidative Stress-induced Neurotoxicity and Mitochondrial Dysfunction in Dopaminergic Neuronal Cells
inferredcites →https://doi.org/10.7150/thno.45922openalex-snapshot
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
inferredcites →https://doi.org/10.7150/thno.45939openalex-snapshot
NLRP3 inflammasome via IL-1β regulates PCSK9 secretion
inferredcites →https://doi.org/10.7759/cureus.12735openalex-snapshot
A Paradigm Shift in the Management of Atherosclerosis: Protective Role of Sirtuins in Atherosclerosis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4903215openalex-extracted
SIRT3-Mediated Mitophagy Ameliorates Atherosclerosis by Attenuating Endothelial LDL Transcytosis in Diabetes
inferred← citeshttps://doi.org/10.1002/advs.202307256openalex-snapshot
Role of Argininosuccinate Synthase 1 ‐Dependent L‐Arginine Biosynthesis in the Protective Effect of Endothelial Sirtuin 3 Against Atherosclerosis
inferred← citeshttps://doi.org/10.1002/advs.77280openalex-snapshot
CDK4/MERCs/PINK1 Axis Drives PFOA/HFPO‐TA‐Induced Cardiac Senescence via Mitophagy Defect and cGAS‐STING Activation: In Vitro Amelioration by Cycloastragenol
inferred← citeshttps://doi.org/10.1002/agm2.70058openalex-snapshot
Predictive Value of Triglyceride/ HDL ‐C Ratio for Unplanned Coronary Revascularization in Elderly Patients With Type 2 Diabetes and Coronary Artery Disease: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1002/cbf.3860openalex-snapshot
Sirtuins and autophagy in lipid metabolism
inferred← citeshttps://doi.org/10.1002/mco2.70451openalex-snapshot
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): The Multifaceted Biology, Diseases, and Pharmaceutical Interventions
inferred← citeshttps://doi.org/10.1002/tox.24019openalex-snapshot
Pb( NO 3 ) 2 induces cell apoptosis through triggering of reactive oxygen species accumulation and disruption of mitochondrial function via SIRT3 / SOD2 pathways
inferred← citeshttps://doi.org/10.1002/viw.20240068openalex-snapshot
Enhanced activation of retinal progenitor cells by zinc silicate bioceramics for effective functional restoration in retinal degenerative diseases
inferred← citeshttps://doi.org/10.1007/s00395-025-01100-5openalex-snapshot
Evolocumab attenuates myocardial ischemia/reperfusion injury by blocking PCSK9/LIAS-mediated cuproptosis of cardiomyocytes
inferred← citeshttps://doi.org/10.1007/s10557-026-07843-0openalex-snapshot
Targeting SIRT3 in Diabetic Cardiomyopathy: Mechanism-Based Therapeutic Strategies
inferred← citeshttps://doi.org/10.1007/s11010-025-05459-wopenalex-snapshot
Molecular mechanisms of PCSK9 in cardiology: therapeutic implications and clinical impacts on the cardiorenal axis
inferred← citeshttps://doi.org/10.1007/s12272-025-01542-4openalex-snapshot
Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases
inferred← citeshttps://doi.org/10.1007/s13577-025-01174-2openalex-snapshot
Nimodipine ameliorates subarachnoid hemorrhage-induced neuroinflammation and injury by protecting mitochondrial function and regulating autophagy
inferred← citeshttps://doi.org/10.1016/b978-0-443-45380-9.00018-3openalex-snapshot
Sirtuins and energy homeostasis
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.11.026openalex-snapshot
Neg-entropy is the true drug target for chronic diseases
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102533openalex-snapshot
Obesity-induced neuronal senescence: Unraveling the pathophysiological links
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102654openalex-snapshot
Roles of SIRT3 in cardiovascular and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2023.06.971openalex-snapshot
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
inferred← citeshttps://doi.org/10.1016/j.athplu.2025.12.001openalex-snapshot
PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosis
inferred← citeshttps://doi.org/10.1016/j.bbadis.2026.168436openalex-snapshot
PCSK9 as a mediator of monocytes transendothelial activation in obstructive sleep apnoea: A translational study
inferred← citeshttps://doi.org/10.1016/j.bbrc.2024.151081openalex-snapshot
PCSK9 promotes vascular neointimal hyperplasia through non-lipid regulation of vascular smooth muscle cell proliferation, migration, and autophagy
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116563openalex-snapshot
PCSK9 inhibitor attenuates cardiac fibrosis in reperfusion injury rat by suppressing inflammatory response and TGF-β1/Smad3 pathway
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.116004openalex-snapshot
SIRT3 regulates mitochondrial function: A promising star target for cardiovascular disease therapy
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116481openalex-snapshot
Research progress on Sirtuins (SIRTs) family modulators
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.116929openalex-snapshot
Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubs
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117739openalex-snapshot
Endothelial cell Ass1 inhibits arteriosclerotic calcification in diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.178521openalex-snapshot
The efficacy of proprotein convertase subtilisin/kexin 9 inhibitors for coronary atherosclerotic plaque burden and phenotype: A meta-analysis and trial sequential analysis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2026.178777openalex-snapshot
Evolocumab alleviates atherogenesis by inhibiting inflammation-mediated endothelial cell activation via the PI3K/AKT/NF-κB pathway
inferred← citeshttps://doi.org/10.1016/j.exger.2025.112701openalex-snapshot
PCSK9 affects vascular senescence through the SIRT1 pathway
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2026.01.045openalex-snapshot
Inclisiran attenuates Alzheimer's disease-like changes by suppressing microvascular endothelial ferroptosis to preserve blood-brain barrier integrity
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115377openalex-snapshot
SIRT3 attenuates sepsis-induced EndMT and cardiac remodeling by facilitating mitophagy process via PINK1/Parkin signaling
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115907openalex-snapshot
Diagnostic and therapeutic potential of PCSK9 in diabetic tubulopathy: Evidence from observational and experimental studies
inferred← citeshttps://doi.org/10.1016/j.jacbts.2026.101624openalex-snapshot
Endothelial Cells at the Crossroad of Atherosclerosis and Metabolic Dysfunction–Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.06.063openalex-snapshot
Recent advances in targeted therapy for inflammatory vascular diseases
inferred← citeshttps://doi.org/10.1016/j.mvr.2026.104925openalex-snapshot
The possible role of PCSK9 inhibitors in cardiac syndrome X: Bridging microvascular dysfunction, endothelial pathobiology, and molecular pharmacotherapy
inferred← citeshttps://doi.org/10.1016/j.niox.2024.09.006openalex-snapshot
Hydrogen sulfide upregulates SIRT1 to inhibit ox-HDL-induced endothelial cell damage and mitochondrial dysfunction
inferred← citeshttps://doi.org/10.1016/j.pharmr.2026.100140openalex-snapshot
Are we underestimating the benefits of lipid-lowering therapies?
inferred← citeshttps://doi.org/10.1016/j.phymed.2026.158080openalex-snapshot
Hyperoside stabilizes ACAT1 to promote fatty acid oxidation and attenuate kidney fibrosis via the L-carnitine–SIRT3 axis
inferred← citeshttps://doi.org/10.1021/acscentsci.5c00023openalex-snapshot
Unraveling Small Molecule-Mediated Sirtuin 3 Activation at a Distinct Binding Site for Cardioprotective Therapies
inferred← citeshttps://doi.org/10.1038/s41598-025-26495-yopenalex-snapshot
Effect of PCSK9 inhibitors on the quality of life in patients with acute coronary syndromes — exploratory analysis of the EMSIACS trial
inferred← citeshttps://doi.org/10.1038/s41598-025-31063-5openalex-snapshot
Overexpression of PRDX2 alleviates chronic thromboembolic pulmonary hypertension by modulating inflammation and mitophagy
inferred← citeshttps://doi.org/10.1039/d4sd00317aopenalex-snapshot
The development of GFETs for biometric applications
inferred← citeshttps://doi.org/10.1080/17512433.2026.2667341openalex-snapshot
Potential beneficial effect of treatment with PCSK9 inhibitors on vascular endothelial dysfunction: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1097/tp.0000000000005461openalex-snapshot
PKM2 Drives Lactate-mediated Fibrosis in Liver Transplantation
inferred← citeshttps://doi.org/10.1099/jmm.0.002114openalex-snapshot
Effect of evolocumab on the gut microbiota in patients with acute myocardial infarction
inferred← citeshttps://doi.org/10.1101/2024.08.22.609192openalex-snapshot
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
inferred← citeshttps://doi.org/10.1111/apha.14272openalex-snapshot
The pleiotropic effects of PCSK9 in cardiovascular diseases beyond cholesterol metabolism
inferred← citeshttps://doi.org/10.1111/jcmm.71206openalex-snapshot
PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia
inferred← citeshttps://doi.org/10.1155/2024/5324127openalex-snapshot
Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization Study
inferred← citeshttps://doi.org/10.1155/sci/6280416openalex-snapshot
miR‐329‐3p in Bone Marrow Mesenchymal Stem Cells‐Derived Exosomes Promotes Bone Regeneration in Diabetic Fractures by Alleviating the SIRT3‐Mediated Oxidative Stress via Inhibiting LSD1
inferred← citeshttps://doi.org/10.1159/000540083openalex-snapshot
Early Use of PCSK9 Inhibitors in the Prognosis of Patients with Acute Coronary Syndrome by Protecting Vascular Endothelial Function
inferred← citeshttps://doi.org/10.1161/jaha.124.036555openalex-snapshot
Exercise Alleviates Cardiovascular Diseases by Improving Mitochondrial Homeostasis
inferred← citeshttps://doi.org/10.1172/jci181928openalex-snapshot
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
inferred← citeshttps://doi.org/10.1186/s11658-023-00482-5openalex-snapshot
MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4
inferred← citeshttps://doi.org/10.1186/s11658-024-00599-1openalex-snapshot
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
inferred← citeshttps://doi.org/10.1186/s11658-025-00838-zopenalex-snapshot
PCSK9 inhibition ameliorates microplastic-induced endothelial redox imbalance via SIRT6 modulation
inferred← citeshttps://doi.org/10.1186/s12891-024-07674-wopenalex-snapshot
PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13020-025-01097-yopenalex-snapshot
Aurantio-obtusin improves obesity and protects hepatic inflammation by rescuing mitochondrial damage in overwhelmed brown adipose tissue
inferred← citeshttps://doi.org/10.1186/s40001-026-04211-4openalex-snapshot
The interaction between remnant cholesterol and diabetes mellitus on the prognosis of acute myocardial infarction
inferred← citeshttps://doi.org/10.14336/ad.2024.1713openalex-snapshot
PCSK9 in Vascular Aging and Age-Related Diseases
inferred← citeshttps://doi.org/10.1507/endocrj.ej23-0359openalex-snapshot
Protective effect of alirocumab, a PCSK9 inhibitor, on the sciatic nerve of rats with diabetic peripheral neuropathy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-5331443/v1openalex-snapshot
Impact of Lipid-Lowering Therapy on Pancreatic Health: Insights from Mendelian Randomization
inferred← citeshttps://doi.org/10.31083/j.rcm2410286openalex-snapshot
Novel Low-Density Lipoprotein Cholesterol Reduction Therapies for the Secondary Prevention of Cardiovascular Disease
inferred← citeshttps://doi.org/10.3389/fcvm.2024.1417044openalex-snapshot
Expression of pro- and anti-inflammatory cytokines during anti-proprotein convertase subtilisin/kexin type 9 therapy in patients with statin-resistant familial hypercholesterolemia
inferred← citeshttps://doi.org/10.3389/fcvm.2025.1678992openalex-snapshot
Metabolic dysregulation in the heart in obesity-associated HFpEF
inferred← citeshttps://doi.org/10.3389/fendo.2023.1191426openalex-snapshot
Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy
inferred← citeshttps://doi.org/10.3389/fendo.2024.1335489openalex-snapshot
Causal relationship between PCSK9 inhibitor and primary glomerular disease: a drug target Mendelian randomization study
inferred← citeshttps://doi.org/10.3389/fendo.2025.1494438openalex-snapshot
Investigation of the interplay of PCSK9, cardiac dynamics, oxidative stress in coronary artery disease: case-control study
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1791961openalex-snapshot
Research progress on targeted regulatory proteins in the prevention and treatment of atherosclerosis
inferred← citeshttps://doi.org/10.3389/fmed.2024.1408760openalex-snapshot
PCSK9 inhibitors ameliorate arterial stiffness in ACS patients: evidences from Mendelian randomization, a retrospective study and basic experiments
inferred← citeshttps://doi.org/10.3389/fmed.2024.1509168openalex-snapshot
PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro
inferred← citeshttps://doi.org/10.3389/fphar.2024.1353848openalex-snapshot
Association between PCSK9 inhibitors and acute kidney injury: a pharmacovigilance study
inferred← citeshttps://doi.org/10.3389/fphar.2025.1555508openalex-snapshot
Indirect comparison of the efficacy and safety of alirocumab and evolocumab on major cardiovascular events: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.3389/fphar.2025.1668718openalex-snapshot
SIRT1: The first key to unlocking the mystery of cardiovascular diseases
inferred← citeshttps://doi.org/10.3389/fphar.2026.1800539openalex-snapshot
Evolocumab early reduces IL-1β/IL-17A and improves left ventricular function in STEMI: an observational study in the real world
inferred← citeshttps://doi.org/10.3389/fphys.2023.1216267openalex-snapshot
Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes
inferred← citeshttps://doi.org/10.3390/antiox13040455openalex-snapshot
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
inferred← citeshttps://doi.org/10.3390/biom15091240openalex-snapshot
The Impact of PCSK9 on Diabetic Cardiomyopathy: Mechanisms and Implications
inferred← citeshttps://doi.org/10.3390/biomedicines12122720openalex-snapshot
Mitochondrial Dysfunction in Atrial Fibrillation: The Need for a Strong Pharmacological Approach
inferred← citeshttps://doi.org/10.3390/cells13191662openalex-snapshot
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
inferred← citeshttps://doi.org/10.3390/ijms25105087openalex-snapshot
MiR-148a-3p/SIRT7 Axis Relieves Inflammatory-Induced Endothelial Dysfunction
inferred← citeshttps://doi.org/10.3390/ijms262110529openalex-snapshot
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia
inferred← citeshttps://doi.org/10.3390/ijms27146473openalex-snapshot
PCSK9 as a Potential Regulator of Endothelial Dysfunction: Mechanistic Insights and Future Directions
inferred← citeshttps://doi.org/10.3390/jcm13175040openalex-snapshot
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes
inferred← citeshttps://doi.org/10.3390/metabo14070388openalex-snapshot
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
inferred← citeshttps://doi.org/10.3390/ph17070919openalex-snapshot
Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment
inferred← citeshttps://doi.org/10.3390/ph18081095openalex-snapshot
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis
inferred← citeshttps://doi.org/10.34133/research.0378openalex-snapshot
Melatonin Mitigates Atrazine-Induced Renal Tubular Epithelial Cell Senescence by Promoting Parkin-Mediated Mitophagy
inferred← citeshttps://doi.org/10.3724/aauj.2024088openalex-snapshot
Construction and identification of 3D4/21 cell line with SIRT3 gene knockout based on CRISPR/Cas9 technology
inferred← citeshttps://doi.org/10.6084/m9.figshare.25929059openalex-snapshot
Additional file 1 of SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells
inferred← citeshttps://doi.org/10.6084/m9.figshare.26610723openalex-snapshot
Additional file 1 of MiR-15b-5p and PCSK9 inhibition reduces lipopolysaccharide-induced endothelial dysfunction by targeting SIRT4
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749616openalex-snapshot
Additional file 1 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749619openalex-snapshot
Additional file 2 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749622openalex-snapshot
Additional file 3 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749625openalex-snapshot
Additional file 4 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749628openalex-snapshot
Additional file 5 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749631openalex-snapshot
Additional file 6 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26749634openalex-snapshot
Additional file 7 of PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
inferred← citeshttps://doi.org/10.7717/peerj.17676openalex-snapshot
PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.